Skip to content

DR M-F SPADA

Active
Private limited companyfounded 2006active for 20 yearsHoefijzerstraat 10, 1970 Wezembeek-Oppem, BelgiumKBO/BCE: BE 0881.028.630

From the official registers: KBO 19 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR M-F SPADA has been active since 2006 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry. The 2025 annual accounts show equity of €550,389 and a net result of €102,036. Equity has been growing by about 9.8% per year since 2018. Its solvency ranks better than 63% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 28-04-2006 Normal situation
Activity
Specialist medical practice NACE 86220
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€166,868
▲ 13.4%
Turnover
≈ €310,000
estimated
Profit
€102,036
▲ 3.3%
Equity
€550,389
▲ 13.2%
Total assets
€733,878
▲ 5.9%
Filed on 30-08-2026, 30 days after the deadlineat the National Bank
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €733,878Figures for financial year 2025 (filed on 31-08-2026)Equity €550,389 (75.0% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 50% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+5
equity 75.0% of total assets
Liquidity 62+2
short-term debt 19.5% · cash 14.7%
Profitability 86-1
return on assets 13.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.3 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: < 0.1%▼ -0.2 percentage points vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.94 (3.51 in 2024), above the usual 1.5. Short-term debt is 19.5% and cash 14.7% of total assets. 25% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 64% of them on solvency, 41% on liquidity, 37% on profitability and 56% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €733,878
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 31-08-2026)
NBB · annual accounts
lowers risk · Equity €550,389 (75.0% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 30 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
30 days late
2024
19 days late
2023
29 days late
2022
60 days late
2021
82 days late
2020
6 days late
2019
111 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 48 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

raises risk · Administrative warnings in the KBO publications
The FPS Economy published 1 notice about the company, such as a strike-off for address, accounts or UBO, or its withdrawal.
KBO publications
Publications
UBO non-compliance
Searched, nothing found (1)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline

Key points

  • Positive: 5th oldest company in Wezembeek-Oppem, Health and social work sectorin the Checked rankings No. 5 View
  • Positive: 8 profitable years in a rowprofit 2025: €102,036 8 years View

Comparable companies

These companies have the same main activity as DR M-F SPADA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €671,000 and €759,000, founded between 2004 and 2007.

CompanyTotal assetsGross margin
DR M-F SPADA Wezembeek-Oppem€733,878€166,868
DOKTER SASKIA DEHING, ANESTHESIST Hoeilaart€670,968€152,944
DOCTEUR LACROIX CHRISTOPHE, ANESTHESIE-REANIMATION ET URGENCE Boussu€714,136€168,075
Cabinet Médical Docteur BROUILLARD Vincent Elsene€718,965€157,597
DOCTEUR CLARENCE KARLER Ukkel€759,458€170,368
Onghena Gent€696,458€157,976
Docteur Yann De BAST Sint-Jans-Molenbeek€754,317€172,304
Full comparison

Documents

Annual accounts at the NBB

All 19 annual accounts

Articles and registers

Key facts about DR M-F SPADA

What is the company number of DR M-F SPADA?
The company number of DR M-F SPADA is 0881.028.630. The VAT number is the same number with BE in front: BE 0881.028.630.
Where is DR M-F SPADA based?
The registered office is at Hoefijzerstraat 10, 1970 Wezembeek-Oppem.Company details
What does DR M-F SPADA do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR M-F SPADA?
The legal form of DR M-F SPADA is Private limited company (BV).
When was DR M-F SPADA founded?
DR M-F SPADA was founded on 28-04-2006.
Is DR M-F SPADA still active?
Yes, DR M-F SPADA is an active enterprise in the KBO register.
What is the turnover of DR M-F SPADA?
The turnover in financial year 2025 is ≈ €310,000. This figure is estimated from the gross margin of €166,868 and 43 comparable companies (NACE 86220). It probably lies between €260,000 and €410,000.Financials
Is DR M-F SPADA profitable?
In financial year 2025, DR M-F SPADA made a profit of €102,036.
Where can I find the annual accounts of DR M-F SPADA?
DR M-F SPADA filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR M-F SPADA due?
DR M-F SPADA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.